by Elena Iemma | May 17, 2021 | Featured, News
PROVIDENCE, RI, May 17, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces the publication “Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation” in NPJ Vaccines. This research identifies...
by Elena Iemma | May 13, 2021 | Featured, News
PROVIDENCE, RI, May 13, 2021 /PRNewswire/ — EpiVax Therapeutics, Inc. (“EVT”) announces the publication “Multi‑step screening of neoantigens’ HLA and TCR‑interfaces improves prediction of survival” in Scientific Reports. This study demonstrates a superior method...
by Elena Iemma | Apr 21, 2021 | Featured, Thinking Out Loud -Blog
Tregitopes: What Did Nature Intend? Hey everybody, it’s a good idea to pay attention to the forces of Nature, right? When we discovered that IgG (as in monoclonals) contained Treg epitopes (and named them “Tregitopes”) in 2008, we knew that this discovery was a...
by Elena Iemma | Feb 25, 2021 | Featured, Thinking Out Loud -Blog
When EpiVax CEO/CSO Annie De Groot began her decades-long focus on HIV vaccine research in the early 90’s, she couldn’t have predicted the implications for the COVID-19 pandemic…. Or perhaps she did! Interviewed by Michael Dumiak for August 2020 issue of IAVI, Annie...
by Annie De Groot | Aug 25, 2017 | Events, Featured
[Updated] View Event Photos! The Westin Immunogenicity Seminar is a unique forum for industry and academic professionals to share ideas, present research updates and network with potential collaborators. The purpose of this seminar is to bridge the gap...